DNAprint Genomics (DNAG)

[MattG]

Unfortunately, the naked shorting is not something that is "just happening" to DNAG as if the DNAG stock symbol was randomly selected as a passive victim in all this.

The continued dilution coupled with the known intent to continually dilute and a weak balance sheet make DNAG an ideal target for the shorters. With this mix, they can not lose.

I agree with Chris that strong financials will turn the tide on shorting but the other part of the equation is to stop the dilution and the intent to dilute.